WO2006042574A3 - Natriumascorbat-solubilisat - Google Patents

Natriumascorbat-solubilisat Download PDF

Info

Publication number
WO2006042574A3
WO2006042574A3 PCT/EP2005/004993 EP2005004993W WO2006042574A3 WO 2006042574 A3 WO2006042574 A3 WO 2006042574A3 EP 2005004993 W EP2005004993 W EP 2005004993W WO 2006042574 A3 WO2006042574 A3 WO 2006042574A3
Authority
WO
WIPO (PCT)
Prior art keywords
solubilisate
sodium ascorbate
tocopherols
foodstuffs
polysorbate
Prior art date
Application number
PCT/EP2005/004993
Other languages
English (en)
French (fr)
Other versions
WO2006042574A2 (de
Inventor
Dariush Behnam
Original Assignee
Bh Aquanova German Solubilisat
Dariush Behnam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bh Aquanova German Solubilisat, Dariush Behnam filed Critical Bh Aquanova German Solubilisat
Priority to EP05743331A priority Critical patent/EP1807047A2/de
Priority to US11/665,534 priority patent/US20090048334A1/en
Publication of WO2006042574A2 publication Critical patent/WO2006042574A2/de
Publication of WO2006042574A3 publication Critical patent/WO2006042574A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Beschrieben wird ein Solubilisat bestehend aus einer wässrigen Lösung von Alkali- und/oder Erdalkalisalzen der Ascorbinsäure für Lebensmittel, Kosmetika und dergleichen, sowie aus einem Emulgator mit einem HLB-Wert von 9 bis 18, zum Beispiel Polysorbat, das zweckmäßig weiterhin ein oder mehrere mittelkettige Triglyceride und/oder ein oder mehrere Tocopherole aufweist.
PCT/EP2005/004993 2004-10-20 2005-05-09 Natriumascorbat-solubilisat WO2006042574A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05743331A EP1807047A2 (de) 2004-10-20 2005-05-09 Natriumascorbat-solubilisat
US11/665,534 US20090048334A1 (en) 2004-10-20 2005-05-09 Sodium ascorbate solubilisate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004051245.0 2004-10-20
DE102004051245A DE102004051245A1 (de) 2004-10-20 2004-10-20 Vitamin C-Solubilisat

Publications (2)

Publication Number Publication Date
WO2006042574A2 WO2006042574A2 (de) 2006-04-27
WO2006042574A3 true WO2006042574A3 (de) 2006-08-03

Family

ID=34980139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/004993 WO2006042574A2 (de) 2004-10-20 2005-05-09 Natriumascorbat-solubilisat

Country Status (4)

Country Link
US (1) US20090048334A1 (de)
EP (1) EP1807047A2 (de)
DE (1) DE102004051245A1 (de)
WO (1) WO2006042574A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010033458B4 (de) 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
DE102011105703A1 (de) 2011-06-22 2012-12-27 Wolfgang Langhoff Diätetikum zur Behandlung mitochondrialer Dysfunktionen
WO2023200792A1 (en) * 2022-04-11 2023-10-19 Impossible Foods Inc. Reductant treatment methods for food product precursors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800824A1 (de) * 1996-03-11 1997-10-15 Basf Aktiengesellschaft Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
US6274169B1 (en) * 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
EP1338271A1 (de) * 2001-11-30 2003-08-27 AQUANOVA German Solubilisate Technologies (AGT) GmbH Wässrige Lösung von Ascorbinsäure
WO2004012707A1 (de) * 2002-07-24 2004-02-12 Basf Aktiengesellschaft Suspensionen von salzen der ascorbinsäure und ihre verwendung als antioxidantien

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1464797A (en) * 1973-08-02 1977-02-16 American Cyanamid Co Injectable liquid vitamin preparation
DE60014255T2 (de) * 1999-07-06 2005-11-03 Dsm Ip Assets B.V. Zusammensetzung, die fettlösliche Substanzen in einer Kohlenhydratmatrix enthält
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800824A1 (de) * 1996-03-11 1997-10-15 Basf Aktiengesellschaft Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
US6274169B1 (en) * 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
EP1338271A1 (de) * 2001-11-30 2003-08-27 AQUANOVA German Solubilisate Technologies (AGT) GmbH Wässrige Lösung von Ascorbinsäure
WO2004012707A1 (de) * 2002-07-24 2004-02-12 Basf Aktiengesellschaft Suspensionen von salzen der ascorbinsäure und ihre verwendung als antioxidantien

Also Published As

Publication number Publication date
WO2006042574A2 (de) 2006-04-27
US20090048334A1 (en) 2009-02-19
DE102004051245A1 (de) 2006-04-27
EP1807047A2 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
WO2007070517A3 (en) Fexofenadine suspension formulation
WO2008090066A3 (en) Stabilization of uv-sensitive active ingredients
WO2007045252A3 (en) An edible composition
EP1550448A4 (de) Histamin-freisetzungshemmer
NO20090692L (no) Farmasoytiske og kostholdsprodukter som omfatter vitamin K2
WO2005116003A3 (de) Substituierte oxazol-benzoisothiazoldioxidderivate, verfahren zu deren herstellung und deren verwendung
WO2005030129A3 (en) Quinoline potassium channel inhibitors
AR054610A1 (es) Composiciones similares a batido que contienen agente de solidificacion y metodo para prepararlas y usarlas
WO2006107820A3 (en) Lignan-containing compositions
AU2003235696A1 (en) Substituted 4-aminopyridine derivatives used as pest control agents
WO2008025819A3 (en) Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
WO2004041257A3 (en) Novel nutraceutical compositions comprising epigallocatechin gallate
WO2005042478A3 (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
BRPI0704096E2 (pt) método para reduzir significantemente os nìveis de adstringência e amargor em composições de polifenol, e, composição
WO2010120734A3 (en) High fiber nutritional emulsions
EP1243185A3 (de) Transparente Mikroemulsionen mit hohem Ölgehalt
WO2006042574A3 (de) Natriumascorbat-solubilisat
WO2006117602A3 (en) Use of amide derivatives as taste-modifying agents, flavouring compositions and products containing them
EP1312373A4 (de) Antiallergische verbindungen und diese enthaltende medikamente, nahrungsmittel, getränke oder kosmetika sowie verfahren zu deren herstellung
WO2008095093A3 (en) Method of increasing cellular function and health of glutathione deficient animals
WO2004039326A3 (en) Propofol with cysteine
EP1198994A3 (de) Heilnahrungsmittel
WO2006056304A3 (en) Control of indoleamine 2,3 deoxygenase expression and activity
WO2006014877A3 (en) Potassium channel inhibitors
WO2005030792A3 (en) Quinoline potassium channel inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11665534

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005743331

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005743331

Country of ref document: EP